Skip to content
The Nexus
DossierENTITY

Myeloid Therapeutics

Coverage of Myeloid Therapeutics in the Nexus archive.

Earliest in view: May 14 · 11:00 UTCMost recent: May 14 · 11:00 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHMay 14 · 11:00 UTCSTAT NEWS
    STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million

    CREATE Medicines, a biotech company, raises $122 million to develop CAR-T therapies, expanding its pipeline and researching autoimmune diseases. The company was cofounded by Siddhartha Mukherjee and recently rebranded from Myeloid Therapeutics. This funding will propel the company's first CAR-T candidates through human trials.

Myeloid Therapeutics · Dossier · The Nexus